Skip to content

Airway Responsiveness and Inflammation in Adolescent Elite Swimmers: a 3-Year Prospective Follow-up Study

Airway Responsiveness and Inflammation in Adolescent Elite Swimmers: a 3-Year Prospective Follow-up Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00841425
Enrollment
33
Registered
2009-02-11
Start date
2009-02-28
Completion date
2010-06-30
Last updated
2009-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Previously the investigators have found that adolescent elite swimmers, who have been involved in competitive swimming for only a few years, have not developed respiratory symptoms, signs of airway inflammation or airway hyperresponsiveness exept for a slight increase in airway responsiveness to eucapnic voluntary hyperpnea. In the current study, the investigators will be doing a 3-year follow-up study on the swimmers studied previously.

Detailed description

Even though studies suggest that elite sport can cause AHR and airway inflammation, more studies are needed to elucidate how and when AHR and airway inflammation develop; and there is a lack of follow-up studies. The present study will give us a chance to do a follow-up study to register changes in AHR and airway inflammation in athletes without any significant airway changes at baseline.

Interventions

None listed

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 15-19 years * Part of the Danish National Swimming Association's talent program for young swimmers at the baseline study * Informed consent

Exclusion criteria

* Upper respiratory tract infection in the previous 4 weeks (visits will be postponed)

Design outcomes

Primary

MeasureTime frame
Airway responsiveness to eucapnic voluntary hyperpnea and methacholineThree years

Secondary

MeasureTime frame
Airway inflammationThree years

Countries

Denmark

Contacts

Primary ContactLars Pedersen, MD PhD
lars.pedersen@dadlnet.dk(+45) 35 31 30 69

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026